<h3>这个假期在 TipRanks 上享受 70% 的折扣</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，最大化您的投资组合潜力</li>
</ul>
<p>MedPlus Health Services Ltd.（（IN:MEDPLUS））已发布公告。</p>
<p>MedPlus Health Services Ltd. 已披露其子公司 Optival Health Solutions Private Limited 收到了针对位于卡纳塔克邦 Jayanagar 9 街区、T R Nagar 和 Shiggon Haveri 三家门店的药品许可证的三项暂停令。这些暂停令由班加罗尔第三圈和哈维里圈的药品监管局助理主任根据《1940 年药品和化妆品法》第 65 条及相关规则发布，每项暂停适用于三天，并与涉嫌违反这些规定有关。公司估计，临时停业可能导致约 32.4 万印度卢比的潜在收入损失，表明对整体运营的财务影响有限，但突显了对其零售药房网络合规性的持续监管审查。</p>
<p><strong>关于 MedPlus Health Services Ltd. 的更多信息</strong></p>
<p>MedPlus Health Services Ltd. 在印度零售药房和医疗服务行业运营，主要通过其 MedPlus 药房连锁和子公司 Optival Health Solutions Private Limited。该公司专注于在多个州提供处方药、非处方药和相关医疗产品，定位为城市和半城市市场的主要有组织药房参与者。</p>
<p><strong>平均交易量：</strong> 21,726</p>
<p><strong>技术情绪信号：</strong> 买入</p>
<p><strong>当前市值：</strong> 98.84B INR</p>
<p>在 TipRanks 的股票分析页面查看更多关于 MEDPLUS 股票的见解。</p>

<p>MedPlus Health Services Ltd. 宣布其子公司 Optival Health Solutions Private Limited 因涉嫌违反 1940 年《药品和化妆品法》，在卡纳塔克邦的三家门店收到了为期三天的药品许可证暂停。预计这些暂停将导致约 3.24 万印度卢比的潜在收入损失。公司强调了有限的财务影响，但指出监管审查仍在持续</p>

<h3>Claim 70% Off TipRanks This Holiday Season</h3>
<div class="lb-trans"><h3>这个假期在 TipRanks 上享受 70% 的折扣</h3>
</div><ul>
<li>Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions</li>
<li>Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，最大化您的投资组合潜力</li>
</ul>
</div><p>MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has shared an announcement.</p>
<div class="lb-trans"><p>MedPlus Health Services Ltd.（（IN:MEDPLUS））已发布公告。</p>
</div><p>MedPlus Health Services Ltd. has disclosed that its subsidiary Optival Health Solutions Private Limited has received three suspension orders for drug licenses covering three stores in Karnataka, located at Jayanagar 9th Block, T R Nagar, and Shiggon Haveri. The suspensions, issued by Assistant Directors of the Drugs Control Administration in Bangalore Circle-3 and Haveri Circle under Rule 65 of the Drugs and Cosmetics Act, 1940 and corresponding Rules, each apply for a three-day period and are linked to alleged violations of those provisions. The company estimates a combined potential revenue loss of roughly Rs 3.24 lakh from the temporary shutdowns, indicating a limited financial impact relative to overall operations, but highlighting ongoing regulatory scrutiny over compliance in its retail pharmacy network.</p>
<div class="lb-trans"><p>MedPlus Health Services Ltd. 已披露其子公司 Optival Health Solutions Private Limited 收到了针对位于卡纳塔克邦 Jayanagar 9 街区、T R Nagar 和 Shiggon Haveri 三家门店的药品许可证的三项暂停令。这些暂停令由班加罗尔第三圈和哈维里圈的药品监管局助理主任根据《1940 年药品和化妆品法》第 65 条及相关规则发布，每项暂停适用于三天，并与涉嫌违反这些规定有关。公司估计，临时停业可能导致约 32.4 万印度卢比的潜在收入损失，表明对整体运营的财务影响有限，但突显了对其零售药房网络合规性的持续监管审查。</p>
</div><p><strong>More about MedPlus Health Services Ltd.</strong></p>
<div class="lb-trans"><p><strong>关于 MedPlus Health Services Ltd. 的更多信息</strong></p>
</div><p>MedPlus Health Services Ltd. operates in the Indian retail pharmacy and healthcare services industry, primarily through its chain of MedPlus pharmacies and subsidiary Optival Health Solutions Private Limited. The company focuses on providing prescription drugs, over-the-counter medicines and related healthcare products across multiple states, positioning itself as a major organized pharmacy player in urban and semi-urban markets.</p>
<div class="lb-trans"><p>MedPlus Health Services Ltd. 在印度零售药房和医疗服务行业运营，主要通过其 MedPlus 药房连锁和子公司 Optival Health Solutions Private Limited。该公司专注于在多个州提供处方药、非处方药和相关医疗产品，定位为城市和半城市市场的主要有组织药房参与者。</p>
</div><p><strong>Average Trading Volume:</strong> 21,726</p>
<div class="lb-trans"><p><strong>平均交易量：</strong> 21,726</p>
</div><p><strong>Technical Sentiment Signal:</strong> Buy</p>
<div class="lb-trans"><p><strong>技术情绪信号：</strong> 买入</p>
</div><p><strong>Current Market Cap:</strong> 98.84B INR</p>
<div class="lb-trans"><p><strong>当前市值：</strong> 98.84B INR</p>
</div><p>See more insights into MEDPLUS stock on TipRanks’ Stock Analysis page.</p>
<div class="lb-trans"><p>在 TipRanks 的股票分析页面查看更多关于 MEDPLUS 股票的见解。</p>
</div>

MedPlus 的子公司在卡纳塔克邦的三家门店面临为期三天的药品许可证暂停